Phenotypic characteristics and clinical manifestations of inflammatory bowel disease in infants and children under 2 years of age in Liaoning Province, China: five of six infants with IL-10R mutations

References

• Aloi M, Lionetti P, Barabino A, et al. Phenotype and disease course of early-onset pediatric inflammatory bowel disease. Inflamm Bowel Dis. 2014;20:597–605.
   PubMed Web of Science ®Google Scholar
• Guan DX, Yu FH, Wang GL, et al. Single center retrospective study of 184 children with inflammatory bowel disease seen from 2000–2014. Zhonghua Er Ke Za Zhi. 2017;55:493–498.
   PubMedGoogle Scholar
• Loddo I, Romano C. Inflammatory bowel disease: genetics, epigenetics, and pathogenesis. Front Immunol. 2015;6:551.
   PubMed Web of Science ®Google Scholar
• Capriati T, Cardile S, Papadatou B, et al. Pediatric inflammatory bowel disease: specificity of very early onset. Expert Rev Clin Immunol. 2016;12:963–972.
   PubMed Web of Science ®Google Scholar
• Shouval DS, Ebens CL, Murchie R, et al. Large B-cell lymphoma in an adolescent patient with IL-10 receptor deficiency and history of infantile inflammatory bowel disease. J Pediatr Gastroenterol Nutr. 2016;63:e15–e17.
   PubMed Web of Science ®Google Scholar
• Pigneur B, Escher J, Elawad M, et al. Phenotypic characterization of very early-onset IBD due to mutations in the IL10, IL10 receptor alpha or beta gene: a survey of the Genius Working Group. Inflamm Bowel Dis. 2013;19:2820–2828.
   PubMed Web of Science ®Google Scholar
• Moran CJ, Walters TD, Guo CH, et al. IL-10R polymorphisms are associated with very-early-onset ulcerative colitis. Inflamm Bowel Dis. 2013;19:115–123.
   PubMed Web of Science ®Google Scholar
• Oliva-Hemker M, Hutfless S, Al Kazzi ES, et al. Clinical presentation and five-year therapeutic management of very early-onset inflammatory bowel disease in a large North American cohort. J Pediatr. 2015;167:527–532.
   PubMed Web of Science ®Google Scholar
• Snapper SB. Very-early-onset inflammatory bowel disease. Gastroenterol Hepatol. 2015;11:554–556.
   Google Scholar
• Hyams JS. Standardized recording of parameters related to the natural history of inflammatory bowel disease: from Montreal to Paris. Dig Dis. 2014;32:337–344.
   PubMed Web of Science ®Google Scholar
• Levine A, Griffiths A, Markowitz J, et al. Pediatric modification of the Montreal classification for inflammatory bowel disease: the Paris classification. Inflamm Bowel Dis. 2011;17:1314–1321.
   PubMed Web of Science ®Google Scholar
• Conley S, Redeker N. A systematic review of self-management interventions for inflammatory nowel disease. J Nurs Scholarsh. 2016;48:118–127.
   PubMed Web of Science ®Google Scholar
• Malaty HM, Sansgiry S, Artinyan A, et al. Clinical characteristics, and risk factors of chronic anal fissure among a national cohort of patients with inflammatory bowel disease. Dig Dis Sci. 2016;61:861–864.
   PubMed Web of Science ®Google Scholar
• Teng X, Xu LF, Sun M, et al. Efficacy of infliximab in the treatment of Crohn’s disease in children. Zhongguo Dang Dai Er Ke Za Zhi. 2015;17:1088–1092.
   PubMedGoogle Scholar
• Xiao Y, Wang XQ, Yu Y, et al. Comprehensive mutation screening for 10 genes in Chinese patients suffering very early onset inflammatory bowel disease. World J Gastroenterol. 2016;22:5578–5588.
   PubMed Web of Science ®Google Scholar
• Bousfiha A, Jeddane L, Picard C, et al. The 2017 IUIS Phenotypic classification for primary immunodeficiencies. J Clin Immunol. 2018;38:129–143.
   PubMed Web of Science ®Google Scholar
• Levine A, Koletzko S, Turner D, et al. ESPGHAN revised Porto criteria for the diagnosis of inflammatory bowel disease in children and adolescents. J Pediatr Gastroenterol Nutr. 2014;58:795–806.
   PubMed Web of Science ®Google Scholar
• Hu YM, Jiang ZF. Zhu Futang practice of pediatrics. 7th ed. Beijing: People’s Medical Publishing House; 2012. p. 19–39.
   Google Scholar
• Commins S, Steinke JW, Borish L. The extended IL-10 superfamily: IL-10, IL-19, IL-20, IL-22, IL-24, IL-26, IL-28, and IL-29. J Allergy Clin Immunol. 2008;121:1108–1111.
   PubMed Web of Science ®Google Scholar
• Elenkov IJ, Chrousos GP. Stress system – organization, physiology and imunoregulation. Neuroimmunomodulation. 2006;13:257–267.
   PubMed Web of Science ®Google Scholar
• Geng X, Xue J. Expression of Treg/Th17 cells as well as related cytokines in patients with inflammatory bowel disease. Pak J Med Sci. 2016;32:1164–1168.
   PubMed Web of Science ®Google Scholar
• Oh SH, Baek J, Liany H, et al. A synonymous variant in IL10RA affects RNA splicing in paediatric patients with refractory inflammatory bowel disease. J Crohns Colitis. 2016;10:1366–1371.
   PubMed Web of Science ®Google Scholar
• Uhlig HH, Schwerd T, Koletzko S, et al. The diagnostic approach to monogenic very early onset inflammatory bowel disease. Gastroenterology. 2014;147:990–1007.
   PubMed Web of Science ®Google Scholar
• Engelhardt KR, Shah N, Faizura-Yeop I, et al. Clinical outcome in IL-10- and IL-10 receptor-deficient patients with or without hematopoietic stem cell transplantation. J Allergy Clin Immunol. 2013;131:825–830.
   PubMed Web of Science ®Google Scholar
• Shouval DS, Biswas A, Kang YH, et al. Interleukin 1b mediates intestinal inflammation in mice and patients with interleukin 10 receptor deficiency. Gastroenterology. 2016;151:1100–1104.
   PubMed Web of Science ®Google Scholar
• Peng K, Qian X, Huang Z, et al. Blood transplantation corrects very early-onset inflammatory bowel disease in Chinese patients with IL10RA-associated immune deficiency. Inflamm Bowel Dis. 2018;24:1416–1427.
   PubMed Web of Science ®Google Scholar
• Karaca NE, Aksu G, Ulusoy E, et al. Early diagnosis and hematopoietic stem cell transplantation for IL10R deficiency leading to very early-onset inflammatory bowel disease are essential in familial cases. Case Rep Immunol. 2016;2016:5459029.
   PubMedGoogle Scholar
• Glocker EO, Kotlarz D, Boztug K, et al. Inflammatory bowel disease and mutations affecting the interleukin-10 receptor. N Engl J Med. 2009;361:2033–2045.
   PubMed Web of Science ®Google Scholar
• Short SS, Dubinsky MC, Rabizadeh S, et al. Distinct phenotypes of children with perianal perforating Crohn’s disease. J Pediatr Surg. 2013;48:1301–1305.
   PubMed Web of Science ®Google Scholar
• Adler J, Dong S, Eder SJ, et al. Perianal Crohn disease in a large multicenter pediatric collaborative. J Pediatr Gastroenterol Nutr. 2017;64:e117–e124.
   PubMed Web of Science ®Google Scholar
• Al-Hussaini A, El Mouzan M, Hasosah M, et al. Clinical pattern of early-onset inflammatory bowel disease in Saudi Arabia: a multicenter national study. Inflamm Bowel Dis. 2016;22:1961–1970.
   PubMed Web of Science ®Google Scholar
• Kotlarz D, Beier R, Murugan D, et al. Loss of interleukin-10 signaling and infantile inflammatory bowel disease: implications for diagnosis and therapy. Gastroenterology. 2012;143:347–355.
   PubMed Web of Science ®Google Scholar
• Charbit-Henrion F, Parlato M, Hanein S, et al. Diagnostic yield of next-generation sequencing in very early-onset inflammatory bowel diseases: a multicenter study. J Crohns Colitis. 2018. DOI:10.1093/ecco-jcc/jjy068.
   PubMed Web of Science ®Google Scholar
• Begue B, Verdier J, Rieux-Laucat F, et al. Defective IL10 signaling defining a subgroup of patients with inflammatory bowel disease. Am J Gastroenterol. 2011;106:1544–1555.
   PubMed Web of Science ®Google Scholar
• Ye Z, Zhou Y, Huang Y, et al. Phenotype and management of infantile-onset inflammatory bowel disease: experience from a tertiary care center in China. Inflamm Bowel Dis. 2017;23:2154–2164.
   PubMed Web of Science ®Google Scholar